An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.
暂无分享,去创建一个
J. Vose | M. Czuczman | R. Bouabdallah | H. Tilly | P. Zinzani | P. Zinzani | C. Haioun | C. Reeder | T. Witzig | R. Buckstein | A. Ervin‐Haynes | D. Pietronigro | J. Polikoff | A. Ervin-Haynes | P. Guo